Tiffany Troso-Sandoval, MD

Medical Oncologist, CEO/Founder of Winning The Cancer Journey, LLC

Medical School

Weill Medical College of Cornell University, New York, NY

Residency

Internal Medicine, New York Hospital/Cornell University, NY

Fellowship(s)

Medical Oncology, Memorial Sloan-Kettering Cancer Center, NY

Area of Expertise

  • Women’s Cancers
  • Breast Cancer
  • Gynecologic Oncology
  • Geriatric Oncology
  • Integrative Cancer Care

Years of Experience

Over 25 years

Certifications & Licensure

  • Board Certified in Internal Medicine
  • Board Certified in Medical Oncology
  • Licensed in New York, New Jersey, and Florida (telehealth)

Biography

Dr. Tiffany Troso-Sandoval is a distinguished medical oncologist with over 25 years of expertise in treating women’s cancers. Her career at Memorial Sloan Kettering Cancer Center has been marked by significant contributions to oncology research and patient care. She has a unique ability to explain complex medical information using simple language and relatable examples.

Currently, Dr. Troso-Sandoval is expanding her impact through Winning The Cancer Journey, LLC, where she provides education, guidance, and support to cancer patients nationwide. As Chief Medical Officer of Second Look Oncology, pLLC, she offers virtual medical oncology opinions for patients with breast and gynecological cancers.

Her commitment to patient care extends beyond traditional treatment approaches, incorporating a comprehensive understanding of cancer care that addresses both the physical and emotional aspects of the cancer journey.

Professional Memberships

  • American Society of Clinical Oncology (ASCO)
  • Society of Gynecological Oncologists
  • Society for Integrative Oncology
  • Institute for Functional Medicine

Selected Publications & Presentations

  1. Friedman CF, et al. “Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses.” Nature Medicine. 2024.
  2. Tolaney SM, et al. “Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with HR+, HER2+ advanced breast cancer.” Lancet Oncol. 2020.
  3. Troso-Sandoval TA, Lichtman SM. “Chemotherapy of Ovarian Cancer in Elderly Patients.” Cancer Biol Med. 2015.

featured Articles

Dr. Yara Robertson headshot with flower petals in the background.

Breast Cancer Surgery: Comprehensive Expert Insights

To shed light on this crucial aspect of treatment, we’ve gathered comprehensive insights from Dr. Yara Robertson

A smiling woman in medical attire with text "YARA ROBERTSONS MD FACS, MEDICAL ADVISOR, African American Women and Breast Cancer", indicating an interview topic or feature on health.

Combating Breast Cancer Disparities among Black Women

Despite overall advances in cancer treatment, Black women face higher mortality rates and more aggressive forms of the disease.

Blue watery patterns

Shining a Light on Male Breast Cancer: A New Resource Page

We’re excited to announce the launch of our new page dedicated to Male Breast Cancer.

Featured Interview

Breast Cancer Diagnosis: Why You Shouldn't Rush into Surgery

Testimonial

MEET OUR EXPERT MEDICAL TEAM

Explore the expertise of our medical advisors, who are dedicated to advancing breast cancer awareness, treatment, and support. Connect with our team and discover how their guidance contributes to the resources and insights available within our breast cancer support groups.

Blog

News

Medical Advisors

Survivor Stories